OINDPnews


Proveris Scientific

News

Company files patent applications for novel intranasal delivery system

US-based AirWare Labs says that it has filed patent applications for an intranasal drug delivery system that will include "AirWare Labs' patent-pending disposable sealed cartridge and patent-pending nasal insert system with insufflation plugins, both of which can be filled with medication in powder form." The company currently markets a line of disposable nasal … [Read more...] about Company files patent applications for novel intranasal delivery system

Aegis Therapeutics gets patent for intranasal CNS drug delivery

The US Patent and Trademark Office (USPTO) has awarded US Patent No 8,883,728, "Intranasal administration of active agents to the central nervous system," to Aegis Therapeutics, the company said. The patent covers, "Pharmaceutical compositions and methods for delivering a polypeptide to the central nervous system of a mammal via intranasal administration are … [Read more...] about Aegis Therapeutics gets patent for intranasal CNS drug delivery

LSTM gets grant to study nasal spray flu vaccine versus pneumococcal bacteria

The Bill and Melinda Gates Foundation has awarded a $2.5 million grant to researchers at Liverpool School of Tropical Medicine (LSTM) for a study to determine the effects of nasal spray flu vaccine on pneumococcal bacteria. The 2-year study, to be conducted in conjunction with the Royal Liverpool University Hospital, will recruit almost 300 volunteers, half of … [Read more...] about LSTM gets grant to study nasal spray flu vaccine versus pneumococcal bacteria

Avanir says NDA for AVP-825 unlikely to be approved by PDUFA date

According to Avanir Pharmaceuticals,the FDA has issued a Discipline Review letter in response to the company's NDA for AVP-825 intranasal dry powder sumatriptan requesting that the company "optimize the product-user interface" and conduct additional human factor testing. AVP-825 is delivered using OptiNose's Breath Powdered intranasal delivery device. Although the … [Read more...] about Avanir says NDA for AVP-825 unlikely to be approved by PDUFA date

RespiTech team gets grant for development of inhalable Smartdrops technology

The Australian Research Council has awarded a $521,800 grant to Daniela Traini and Paul Young of the Woolcock Institute's RespiTech group and Patrick Spicer of the University of New South Wales for development of inhalable "Smartdrops" for drug delivery to the lung. The three-year project is designed to develop a microfluidics-based process for creating … [Read more...] about RespiTech team gets grant for development of inhalable Smartdrops technology

Over 700 employees transfered from Almirall to AstraZeneca as part of respiratory drug deal

As AstraZeneca completes the acquisition of Almirall's respiratory drug franchise, which was first announced in July 2014, Almirall says that 719 employees will transfer to AstraZeneca. The deal includes the inhalation R&D company Almirall Sofotec as well as a number of inhalers, including the Eklira/Bretaris/Tudorza aclidinium DPI, the Duaklir Genuair … [Read more...] about Over 700 employees transfered from Almirall to AstraZeneca as part of respiratory drug deal